Biotechnology Analysis & Statistics in the United States, April 2009 (p20)

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: biotech, protein, biomedical, more »

571-600 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

Myriad Genetics, Inc. Financial Analysis

Myriad Genetics, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Myriad) has its major operations in the development and commercialization of novel therapeutic and molecular diagnostic products. The industry player principally operates in the U.S. Myriad has main ...

  • Industries : Genomics, Therapy
  • Countries : United States, World
Illumina, Inc. Financial Analysis

Illumina, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

, is a Molecular Diagnostics firm . The industry player is principally focused into research and developement of DNA and RNA Assays. It develops, manufactures and industry s integrated systems for the ...

  • Industries : In Vitro Diagnostic, Biotechnology
  • Countries : United States
Avigen, Inc. Financial Analysis

Avigen, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Avigen) is a biopharmaceutical industry player engaged in the development and commercialization of small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscula ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States, World, North America
Advanced Cell Technology, Inc. Financial Analysis

Advanced Cell Technology, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(ACT) is engaged in the development and commercialization of the human embryonic stem cell technology in the field of regenerative medicine. The firm 's business is employed in developing and commercializing ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
PDL BioPharma, Inc. Financial Analysis

PDL BioPharma, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(PDL BioPharma) is a specialty biopharmaceutical firm . The industry player is focused on the research and development of innovative novel antibodies to treat patients with cancer and immunological diseases. ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : United States
Accelrys, Inc. Financial Analysis

Accelrys, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Accelrys) is engaged in the development and industry ing of scientific business intelligence software for the aggregation, mining, integration, analysis, simulation, management and interactive reporting ...

  • Industries : Drug Discovery and Development, Software, Biotechnology, Business Services
  • Countries : United States
Insmed Incorporated Financial Analysis

Insmed Incorporated Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

The Firms is developing products for anemia, neutropenia, and autoimmune diseases. The firm ?s products include IPLEX is a complex of recombinant human IGF-1 and its binding protein IGFBP-3 in various ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : United States, World
AutoImmune Inc. Financial Analysis

AutoImmune Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

is development stage Biopharmaceutical Firms which is focused on developing drugs based on oral tolerance to treat cell mediated inflammatory diseases. The industry player is incorporated in California, ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : United States
IR Biosciences Holdings, Inc. Financial Analysis

IR Biosciences Holdings, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

is a development stage biotechnology firm . The industry player through its wholly-owned subsidiary ImmuneRegen BioSciences, Inc. is engaged in the research and development of potential drug candidates, ...

  • Industries : Drug Discovery and Development, Biotechnology
  • Countries : United States
UCB Group Financial Analysis

UCB Group Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

Its product portfolio consists of small, chemically derived molecules and large, antibody-based molecules called, biopharma. UCB develops small chemically derived molecules using their proprietary technologies, ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : World, United States
Halozyme Therapeutics Financial Analysis

Halozyme Therapeutics Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

Its products portfolio depends on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes affecting the extracellular matrix. The firm ?s Enhanze technology ...

  • Industries : Therapy, Biotechnology
  • Countries : United States, World
ZymoGenetics, Inc. Financial Analysis

ZymoGenetics, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(ZymoGenetics) is a biopharmaceutical industry player focused on discovery, development and commercialization of therapeutic protein-based products. The industry player is offering in the areas of hemostasis, ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : United States, World
Emergent BioSolutions Inc. Financial Analysis

Emergent BioSolutions Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Emergent BioSolutions) is a biopharmaceutical industry player which is engaged in the development, manufacture and industry ing of immunobiotics, consisting of vaccines and therapeutics that assist the ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : United States
Neurocrine Biosciences, Inc. Financial Analysis

Neurocrine Biosciences, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

The industry player has developed many of its product candidates dealing with world's largest pharmaceutical industry s such as endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, ...

  • Industries : Pathology, Biotechnology
  • Countries : United States, World
Cepheid Financial Analysis

Cepheid Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

It is engaged in the development, manufacture and industry ing of fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat industry s. These systems allow rapid ...

  • Industries : In Vitro Diagnostic, Biotechnology
  • Countries : United States, World
Antigenics, Inc. Financial Analysis

Antigenics, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Antigenics) is a biotechnology firm . The industry player is focused on the developing superior health care products and technologies for a wide range of cancers, infectious diseases and autoimmune disorders ...

  • Industries : Pathology, Biotechnology
  • Countries : United States
Hemispherx Biopharma, Inc. Financial Analysis

Hemispherx Biopharma, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Hemispherx) is a biopharmaceutical industry player engaged in the clinical development, manufacture, industry ing and distribution of drug therapies that is based on natural immune system enhancing technologies ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : United States
Seattle Genetics, Inc. Financial Analysis

Seattle Genetics, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Seattle) is engaged in the discovery and the development of monoclonal antibody-based drugs to treat cancer and autoimmune diseases. It principally operates in the United States. The industry playe ...

  • Industries : Genomics, Pharmaceutical
  • Countries : United States
Sangamo BioSciences, Inc. Financial Analysis

Sangamo BioSciences, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Sangamo) is a developmental stage biotechnology industry player engaged in the development and commercialization of zinc finger DNA-binding proteins (ZFPs), transcription factors for gene regulation ...

  • Industries : Genomics, Pharmaceutical
  • Countries : United States
Orthovita, Inc. Financial Analysis

Orthovita, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Orthovita) is engaged in offering advanced bone regeneration and soft tissue healing technologies. The industry player is a spine and orthopedic surgical biomaterials industry player involved in the ...

  • Industries : Biomaterial, Pharmaceutical
  • Countries : United States, World
Osiris Therapeutics, Inc. Financial Analysis

Osiris Therapeutics, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Osiris) is an independent biotechnology industry player that commercializes stem cell therapeutic products taken from the adult bone marrow. The industry player is involved in development and sale of ...

  • Industries : Therapy, Biotechnology
  • Countries : United States, World
Commonwealth Biotechnologies, Inc. Financial Analysis

Commonwealth Biotechnologies, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(CBI) is a specialized life sciences industry player engaged in providing macromolecular synthetic and analytical technologies in the areas of bio-defense, laboratory support, and contract research. It ...

  • Industries : Biotechnology
  • Countries : World, United States
Interleukin Genetics Incorporated Financial Analysis

Interleukin Genetics Incorporated Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

It is the biotechnology industry player that has key partnerships with a large consumer products firms . These industry players market nutritional product designed for people who are tested positive fo ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
BioTime, Inc. Financial Analysis

BioTime, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

The industry player principally operates in the United States and Asia. It is incorporated in Emeryville, California and employs 9 people. Global Industry s Direct, the leading business information provider, ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Biotechnology
  • Countries : United States, World
Aastrom Biosciences, Inc. Financial Analysis

Aastrom Biosciences, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

The firm ?s principal business is to develop Tissue Repair Cell (TRC) based products for use in multiple therapeutic areas. Aastrom is incorporated in Michigan, U.S. The industry player is at the development ...

  • Industries : General Medicine and Specialty Medicine, Biotechnology
  • Countries : United States, World
Synthes GmbH Financial Analysis

Synthes GmbH Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

The industry player has operations spread across the US, Latin America, Europe, the Middle East and Asia Pacific. It is incorporated in Solothurn, Switzerland and employs 9,070 people. Synthes? products ...

  • Industries : Biomaterial, Medical Devices
  • Countries : World, Switzerland, United States
Idera Pharmaceuticals, Inc. Financial Analysis

Idera Pharmaceuticals, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(Idera) is a biotechnology industry player focusing on the discovery and development of synthetic deoxyribonucleic acid (DNA)-and ribonucleic acid (RNA)-based drug candidates targeted to Toll-Like Receptors ...

  • Industries : Pathology, Biotechnology
  • Countries : United States, World
Avita Medical Ltd Financial Analysis

Avita Medical Ltd Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

The industry player products include ReCell CellSpray Funhaler and Breath-A-Tech. The industry player is incorporated in Nedlands, Australia and employs fourteen people. Global Industry s Direct, the ...

  • Industries : Healthcare, Biotechnology
  • Countries : World, United States, Australia
AspenBio Pharma, Inc. Financial Analysis

AspenBio Pharma, Inc. Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

(AspenBio) is an emerging biotechnology industry player that is principally engaged in the discovery, development, manufacture, licensing and industry ing of products for human and animal healthcare. ...

  • Industries : Drug and Medication, Biotechnology
  • Countries : United States
Generex Biotechnology Corporation Financial Analysis

Generex Biotechnology Corporation Financial Analysis

  • $ 125
  • Company report
  • April 2009
  • by Global Markets Direct

The industry player focuses on drug delivery system of large molecules in the areas of diabetes, pain management and cancers. It has proprietary and proven advanced technology platform including buccal ...

  • Industries : Drug Delivery Technology, Biotechnology
  • Countries : World, United States, Canada
About 2 900 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Supply in the US

  • September 2014
    11 pages
  • Biological Ther...  

  • United States  

View report >

Vaccine Market In The Us

September 2014

15 Companies

Read our Company Profiles

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

Biogen Idec

United States

Abbott Laboratories

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.